Related Experiment Video
Updated: Jun 5, 2026
05:08
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Osteoporosis in inflammatory bowel disease
1Department of Medicine I, Klinikum Braunschweig, Germany.
Journal of Crohn'S & Colitis
|December 22, 2010
Summary
Inflammatory bowel disease (IBD) patients often experience bone loss and fractures due to disease activity and steroid use. Achieving clinical remission can normalize bone density, while supplementation and bisphosphonates are key treatments.
Area of Science:
- Gastroenterology and Endocrinology
- Bone Metabolism and Inflammatory Diseases
Background:
- Inflammatory bowel disease (IBD) frequently leads to reduced bone mass, affecting younger patients compared to those with postmenopausal osteoporosis.
- A significant subset of IBD patients develop asymptomatic vertebral fractures.
Purpose of the Study:
- To investigate the mechanisms of bone loss in IBD patients.
- To identify risk factors and effective management strategies for bone complications in IBD.
Main Methods:
- The study reviews the pathophysiology of bone loss in IBD, focusing on the role of chronic inflammation and corticosteroid treatment.
- It examines the impact of the tumor necrosis factor-alpha (TNFα)-driven osteoprotegerin system on bone density.
- The abstract discusses the lack of established genetic markers for fracture risk assessment in IBD.
Main Results:
- Chronic inflammation and steroid therapy in IBD patients contribute to bone loss, primarily via the TNFα-osteoprotegerin pathway.
- Long-term clinical remission in IBD often results in the normalization of bone density.
- Vertebral fractures are a common complication, often asymptomatic.
Conclusions:
- IBD patients are at high risk for osteoporosis and fractures, distinct from postmenopausal osteoporosis.
- Management should include calcium and vitamin D supplementation for reduced bone density and bisphosphonates for vertebral fractures.
- Further research is needed for genetic markers to predict fracture risk in IBD.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...